From the Understanding of Maternal Molecules and Mechanisms to Predicting Embryonic Development.

IF 4.3 3区 医学 Q2 OBSTETRICS & GYNECOLOGY
Reproductive Medicine and Biology Pub Date : 2026-02-10 eCollection Date: 2026-01-01 DOI:10.1002/rmb2.70026
Yubao Wei, Akihiro Inoue, Kei Miyamoto
{"title":"From the Understanding of Maternal Molecules and Mechanisms to Predicting Embryonic Development.","authors":"Yubao Wei, Akihiro Inoue, Kei Miyamoto","doi":"10.1002/rmb2.70026","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Embryo quality is a critical determinant of successful outcomes in assisted reproductive technology (ART). Various molecular and cellular mechanisms in oocytes influence embryo quality, and their understanding can lead to the establishment of selection criteria for enhancing implantation rates.</p><p><strong>Methods: </strong>This review summarizes current knowledge on oocyte factors influencing embryo quality, including organelle function, chromosome segregation, maternal transcripts, metabolism, and gene regulation. We also discuss emerging techniques for assessing the fate of embryonic development, such as time-lapse imaging, preimplantation genetic testing for aneuploidy (PGT-A), and artificial intelligence (AI) or machine learning-based prediction models.</p><p><strong>Main findings: </strong>Embryo quality is often determined by maternal factors-driven mechanisms that affect developmental potentials. Advanced technologies such as omics-based profiling and AI-driven analyses offer promising non-invasive assessment tools for embryo quality.</p><p><strong>Conclusion: </strong>Integrating molecular diagnostics of maternal factors with traditional morphological evaluation can refine embryo selection, improving ART success rates. Future research should focus on minimally invasive biomarkers and personalized prediction models.</p>","PeriodicalId":21116,"journal":{"name":"Reproductive Medicine and Biology","volume":"25 1","pages":"e70026"},"PeriodicalIF":4.3000,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12887975/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive Medicine and Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/rmb2.70026","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Embryo quality is a critical determinant of successful outcomes in assisted reproductive technology (ART). Various molecular and cellular mechanisms in oocytes influence embryo quality, and their understanding can lead to the establishment of selection criteria for enhancing implantation rates.

Methods: This review summarizes current knowledge on oocyte factors influencing embryo quality, including organelle function, chromosome segregation, maternal transcripts, metabolism, and gene regulation. We also discuss emerging techniques for assessing the fate of embryonic development, such as time-lapse imaging, preimplantation genetic testing for aneuploidy (PGT-A), and artificial intelligence (AI) or machine learning-based prediction models.

Main findings: Embryo quality is often determined by maternal factors-driven mechanisms that affect developmental potentials. Advanced technologies such as omics-based profiling and AI-driven analyses offer promising non-invasive assessment tools for embryo quality.

Conclusion: Integrating molecular diagnostics of maternal factors with traditional morphological evaluation can refine embryo selection, improving ART success rates. Future research should focus on minimally invasive biomarkers and personalized prediction models.

Abstract Image

Abstract Image

从了解母体分子及其机制到预测胚胎发育。
背景:胚胎质量是辅助生殖技术(ART)成功的关键决定因素。卵母细胞的各种分子和细胞机制影响胚胎质量,了解这些机制可以建立提高着床率的选择标准。方法:综述了影响胚胎质量的卵母细胞因素,包括细胞器功能、染色体分离、母体转录物、代谢和基因调控等方面的研究进展。我们还讨论了评估胚胎发育命运的新兴技术,如延时成像,非整倍体植入前基因检测(PGT-A),以及人工智能(AI)或基于机器学习的预测模型。主要发现:胚胎质量通常是由母体因素驱动的影响发育潜能的机制决定的。基于组学的分析和人工智能驱动的分析等先进技术为胚胎质量提供了有前途的非侵入性评估工具。结论:将母体因素分子诊断与传统形态学评价相结合,可完善胚胎选择,提高ART成功率。未来的研究重点应放在微创生物标志物和个性化预测模型上。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
5.90%
发文量
53
审稿时长
20 weeks
期刊介绍: Reproductive Medicine and Biology (RMB) is the official English journal of the Japan Society for Reproductive Medicine, the Japan Society of Fertilization and Implantation, the Japan Society of Andrology, and publishes original research articles that report new findings or concepts in all aspects of reproductive phenomena in all kinds of mammals. Papers in any of the following fields will be considered: andrology, endocrinology, oncology, immunology, genetics, function of gonads and genital tracts, erectile dysfunction, gametogenesis, function of accessory sex organs, fertilization, embryogenesis, embryo manipulation, pregnancy, implantation, ontogenesis, infectious disease, contraception, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书